Post-translational protein modifications in malaria parasites

Nature Reviews Microbiology

Volumn 13, Issue 3, 2015, Pages 160-172

  Doerig, Christian ^a   Rayner, Julian C ^b   Scherf, Artur ^c   Tobin, Andrew B ^d  

^a MONASH UNIVERSITY   (Australia)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; HISTONE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; PROTOZOAL PROTEIN;

CYTOLOGY; EPIGENETICS; GENE EXPRESSION; GENETIC REGULATION; HISTONE MODIFICATION; HUMAN; LIPID METABOLISM; LIPIDATION; NONHUMAN; PATHOGENESIS; PLASMODIUM; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; ADAPTATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY;

EUKARYOTA;

ADAPTATION, PHYSIOLOGICAL; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; PLASMODIUM; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTOZOAN PROTEINS;

EID: 84923608042     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3402     Document Type: Review

References (120)

1. Murray, C. J. et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379, 413-431 (2012).
2. Dondorp, A. M. et al. Artemisinin resistance: current status and scenarios for containment. Nature Rev. Microbiol. 8, 272-280 (2010).
3. Burrows, J. N., Chibale, K.&Wells, T. N. The state of the art in anti-malarial drug discovery and development. Curr. Top. Med. Chem. 11, 1226-1254 (2011).
4. Bozdech, Z. et al. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 1, E5 (2003).
5. Le Roch, K. G. et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301, 1503-1508 (2003).
6. Macedo, C. S., Schwarz, R. T., Todeschini, A. R., Previato, J. O.&Mendonca-Previato, L. Overlooked post-translational modifications of proteins in Plasmodium falciparum: N-and Oglycosylation - a review. Mem. Inst. Oswaldo Cruz 105, 949-956 (2010).
7. Kimura, E. A., Katzin, A. M.&Couto, A. S. More on protein glycosylation in the malaria parasite. Parasitol. Today 16, 38-40 (2000).
8. Ponts, N. et al. Unraveling the ubiquitome of the human malaria parasite. J. Biol. Chem. 286, 40320-40330 (2011).
9. Issar, N., Roux, E., Mattei, D.&Scherf, A. Identification of a novel post-translational modification in Plasmodium falciparum: protein sumoylation in different cellular compartments. Cell. Microbiol. 10, 1999-2011 (2008).
10. Wang, L. et al. Protein Snitrosylation in Plasmodium falciparum. Antioxid. Redox Signal 20, 2923-2935 (2014).
11. Kehr, S. et al. Protein Sglutathionylation in malaria parasites. Antioxid. Redox Signal 15, 2855-2865 (2011).
12. Talevich, E., Tobin, A. B., Kannan, N.&Doerig, C. An evolutionary perspective on the kinome of malaria parasites. Phil. Trans. R. Soc. B 367, 2607-2618 (2012).
13. Lucet, I. S., Tobin, A., Drewry, D., Wilks, A. F.&Doerig, C. Plasmodium kinases as targets for new-generation antimalarials. Future Med. Chem. 4, 2295-2310 (2013).
14. Anamika, Srinivasan, N.&Krupa, A. A genomic perspective of protein kinases in Plasmodium falciparum. Proteins 58, 180-189 (2005).
15. Ward, P., Equinet, L., Packer, J.&Doerig, C. Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. BMC Genomics 5, 79 (2004).
16. Tewari, R. et al. The systematic functional analysis of Plasmodium protein kinases identifies essential regulators of mosquito transmission. Cell Host Microbe 8, 377-387 (2010).
17. Solyakov, L. et al. Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nature Commun. 2, 565 (2011).
18. Lasonder, E. et al. The Plasmodium falciparum schizont phosphoproteome reveals extensive phosphatidylinositol and cAMP-protein kinase A signaling. J. Proteome Res. 11, 5323-5337 (2012).
19. Treeck, M., Sanders, J. L., Elias, J. E.&Boothroyd, J. C. The phosphoproteomes of Plasmodium falciparum and Toxoplasma gondii reveal unusual adaptations within and beyond the parasites' boundaries. Cell Host Microbe 10, 410-419 (2011).
20. Collins, M. O., Wright, J. C., Jones, M., Rayner, J. C.&Choudhary, J. S. Confident and sensitive phosphoproteomics using combinations of collision induced dissociation and electron transfer dissociation. J. Proteom. 103, 1-14 (2014).
21. Lasonder, E., Treeck, M., Alam, M.&Tobin, A. B. Insights into the Plasmodium falciparum schizont phospho-proteome. Microbes Infect. 14, 811-819 (2012).
22. Pease, B. N. et al. Global analysis of protein expression and phosphorylation of three stages of Plasmodium falciparum intraerythrocytic development. J. Proteome Res. 12, 4028-4045 (2013).
23. Brochet, M. et al. Phosphoinositide metabolism links cGMP-dependent protein kinase G to essential Ca2+ signals at key decision points in the life cycle of malaria parasites. PLoS Biol. 12, e1001806 (2014).
24. Wilkes, J. M.&Doerig, C. The protein-phosphatome of the human malaria parasite Plasmodium falciparum. BMC Genomics 9, 412 (2008).
25. Guttery, D. S. et al. Genome-wide functional analysis of Plasmodium protein phosphatases reveals key regulators of parasite development and differentiation. Cell Host Microbe 16, 128-140 (2014).
26. Nolen, B., Taylor, S.&Ghosh, G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol. Cell 15, 661-675 (2004).
27. Parker, L. L., Atherton-Fessler, S.&Piwnica-Worms, H. p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15. Proc. Natl Acad. Sci. USA 89, 2917-2921 (1992).
28. Collins, C. R. et al. Malaria parasite cGMP-dependent protein kinase regulates blood stage merozoite secretory organelle discharge and egress. PLoS Pathog. 9, e1003344 (2013).
29. Leykauf, K. et al. Protein kinase a dependent phosphorylation of apical membrane antigen 1 plays an important role in erythrocyte invasion by the malaria parasite. PLoS Pathog. 6, e1000941 (2010).
30. Dvorin, J. D. et al. A plant-like kinase in Plasmodium falciparum regulates parasite egress from erythrocytes. Science 328, 910-912 (2010).
31. Dastidar, E. et al. Comprehensive histone phosphorylation analysis and identification of Pf14-3-3 protein as a histone H3 phosphorylation reader in malaria parasites. PLoS ONE 8, e53179 (2012).
32. Billker, O. et al. Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito. Nature 392, 289-292 (1998).
33. Billker, O. et al. Calcium and a calcium-dependent protein kinase regulate gamete formation and mosquito transmission in a malaria parasite. Cell 117, 503-514 (2004).
34. Tewari, R., Dorin, D., Moon, R., Doerig, C.&Billker, O. An atypical mitogen-activated protein kinase controls cytokinesis and flagellar motility during male gamete formation in a malaria parasite. Mol. Microbiol. 58, 1253-1263 (2005).
35. Proud, C. G. eIF2 and the control of cell physiology. Semin. Cell Dev. Biol. 16, 3-12 (2005).
36. Fennell, C. et al. PfeIK1, a eukaryotic initiation factor 2 kinase of the human malaria parasite Plasmodium falciparum, regulates stress-response to amino-acid starvation. Malar. J. 8, 99 (2009).
37. Zhang, M. et al. The Plasmodium eukaryotic initiation factor-2 kinase IK2 controls the latency of sporozoites in the mosquito salivary glands. J. Exp. Med. 207, 1465-1474 (2010).
38. Zhang, M. et al. PK4, a eukaryotic initiation factor 2 (eIF2) kinase, is essential for the development of the erythrocytic cycle of Plasmodium. Proc. Natl Acad. Sci. USA 109, 3956-3961 (2012).
39. Miao, J. et al. Extensive lysine acetylation occurs in evolutionarily conserved metabolic pathways and parasite-specific functions during Plasmodium falciparum intraerythrocytic development. Mol. Microbiol. 89, 660-675 (2013).
40. Tonkin, C. J. et al. Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum. PLoS Biol. 7, e84 (2009).
41. French, J. B., Cen, Y.&Sauve, A. A. Plasmodium falciparum Sir2 is an NAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysine-independent NAD+ glycohydrolase. Biochemistry 47, 10227-10239 (2008).
42. Coleman, B. I. et al. A Plasmodium falciparum histone deacetylase regulates antigenic variation and gametocyte conversion. Cell Host Microbe 16, 177-186 (2014).
43. Mancio-Silva, L., Lopez-Rubio, J. J., Claes, A.&Scherf, A. Sir2a regulates rDNA transcription and multiplication rate in the human malaria parasite Plasmodium falciparum. Nature Commun. 4, 1530 (2013).
44. Guizetti, J.&Scherf, A. Silence, activate, poise and switch! Mechanisms of antigenic variation in Plasmodium falciparum. Cell. Microbiol. 15, 718-726 (2013).
45. Freitas-Junior, L. H. et al. Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites. Cell 121, 25-36 (2005).
46. Lopez-Rubio, J. et al. 5 flanking region of var genes nucleate histone modification patterns linked to phenotypic inheritance of virulence traits in malaria parasites. Mol. Microbiol. 66, 1296-1305 (2007).
47. Chookajorn, T. et al. Epigenetic memory at malaria virulence genes. Proc. Natl Acad. Sci. USA 104, 899-902 (2007).
48. Lopez-Rubio, J. J., Mancio-Silva, L.&Scherf, A. Genome-wide analysis of heterochromatin associates clonally variant gene regulation with perinuclear repressive centers in malaria parasites. Cell Host Microbe 5, 179-190 (2009).
49. Salcedo-Amaya, A. M. et al. Dynamic histone H3 epigenome marking during the intraerythrocytic cycle of Plasmodium falciparum. Proc. Natl Acad. Sci. USA 106, 9655-9660 (2009).
50. Bischoff, E.&Vaquero, C. In silico and biological survey of transcription-associated proteins implicated in the transcriptional machinery during the erythrocytic development of Plasmodium falciparum. BMC Genomics 11, 34 (2010).
51. Cui, L., Miao, J.&Cui, L. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob. Agents Chemother. 51, 488-494 (2007).
52. Fan, Q., An, L.&Cui, L. Plasmodium falciparum histone acetyltransferase, a yeast GCN5 homologue involved in chromatin remodeling. Eukaryot. Cell 3, 264-276 (2004).
53. Miao, J. et al. The MYST family histone acetyltransferase regulates gene expression and cell cycle in malaria parasite Plasmodium falciparum. Mol. Microbiol. 78, 883-902 (2010).
54. Fan, Q., Miao, J., Cui, L.&Cui, L. Characterization of PRMT1 from Plasmodium falciparum. Biochem. J. 421, 107-118 (2009).
55. Volz, J. C. et al. PfSET10, a Plasmodium falciparum methyltransferase, maintains the active var gene in a poised state during parasite division. Cell Host Microbe 11, 7-18 (2012).
56. Cui, L., Fan, Q.&Miao, J. Histone lysine methyltransferases and demethylases in Plasmodium falciparum. Int. J. Parasitol. 38, 1083-1097 (2008).
57. Jiang, L. et al. PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum. Nature 499, 223-227 (2013).
58. Volz, J. et al. Potential epigenetic regulatory proteins localise to distinct nuclear sub-compartments in Plasmodium falciparum. Int. J. Parasitol. 40, 109-121 (2010).
59. Kutateladze, T. G. SnapShot: histone readers. Cell 146, 842-842.e1 (2011).
60. Flueck, C. et al. Plasmodium falciparum heterochromatin protein 1 marks genomic loci linked to phenotypic variation of exported virulence factors. PLoS Pathog. 5, e1000569 (2009).
61. Perez-Toledo, K. et al. Plasmodium falciparum heterochromatin protein 1 binds to tri-methylated histone 3 lysine 9 and is linked to mutually exclusive expression of var genes. Nucleic Acids Res. 37, 2596-2606 (2009).
62. Brancucci, N. M. et al. Heterochromatin protein 1 secures survival and transmission of malaria parasites. Cell Host Microbe 16, 165-176 (2014).
63. Resh, M. D. Covalent lipid modifications of proteins. Curr. Biol. 23, R431-435 (2013).
64. Rees-Channer, R. R. et al. Dual acylation of the 45 kDa gliding-associated protein (GAP45) in Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 149, 113-116 (2006).
65. Jones, M. L., Collins, M. O., Goulding, D., Choudhary, J. S.&Rayner, J. C. Analysis of protein palmitoylation reveals a pervasive role in Plasmodium development and pathogenesis. Cell Host Microbe 12, 246-258 (2012).
66. Wright, M. H. et al. Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach. Nature Chem. 6, 112-121 (2014).
67. Gilson, P. R. et al. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol. Cell Proteom. 5, 1286-1299 (2006).
68. Martin, B. R.&Cravatt, B. F. Large-scale profiling of protein palmitoylation in mammalian cells. Nature Methods 6, 135-138 (2009).
69. Linder, M. E.&Deschenes, R. J. Palmitoylation: policing protein stability and traffic. Nature Rev. Mol. Cell. Biol. 8, 74-84 (2007).
70. Jones, M. L., Tay, C. L.&Rayner, J. C. Getting stuck in: protein palmitoylation in Plasmodium. Trends Parasitol. 28, 496-503 (2012).
71. Frenal, K. et al. Global analysis of apicomplexan protein S-acyl transferases reveals an enzyme essential for invasion. Traffic 14, 895-911 (2013).
72. von Itzstein, M., Plebanski, M., Cooke, B. M.&Coppel, R. L. Hot, sweet and sticky: the glycobiology of Plasmodium falciparum. Trends Parasitol. 24, 210-218 (2008).
73. Cowman, A. F., Berry, D.&Baum, J. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J. Cell Biol. 198, 961-971 (2012).
74. Howe, R., Kelly, M., Jimah, J., Hodge, D.&Odom, A. R. Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum. Eukaryot. Cell 12, 215-223 (2013).
75. Martin, B. R., Wang, C., Adibekian, A., Tully, S. E.&Cravatt, B. F. Global profiling of dynamic protein palmitoylation. Nature Methods 9, 84-89 (2012).
76. Mueller, C. et al. The Toxoplasma protein ARO mediates the apical positioning of rhoptry organelles, a prerequisite for host cell invasion. Cell Host Microbe 13, 289-301 (2013).
77. Cabrera, A. et al. Dissection of minimal sequence requirements for rhoptry membrane targeting in the malaria parasite. Traffic 13, 1335-1350 (2012).
78. Blaskovic, S., Blanc, M.&van der Goot, F. G. What does S-palmitoylation do to membrane proteins? FEBS J. 280, 2766-2774 (2013).
79. Zhang, J., Yang, P. L.&Gray, N. S. Targeting cancer with small molecule kinase inhibitors. Nature Rev. Cancer 9, 28-39 (2009).
80. Talevich, E., Mirza, A.&Kannan, N. Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa. BMC Evol. Biol. 11, 321 (2011).
81. Kato, N. et al. Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility. Nature Chem. Biol. 4, 347-356 (2008).
82. Sebastian, S. et al. A Plasmodium calcium-dependent protein kinase controls zygote development and transmission by translationally activating repressed mRNAs. Cell Host Microbe 12, 9-19 (2012).
83. Siden-Kiamos, I. et al. Plasmodium berghei calcium-dependent protein kinase 3 is required for ookinete gliding motility and mosquito midgut invasion. Mol. Microbiol. 60, 1355-1363 (2006).
84. Chapman, T. M. et al. Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1). Bioorg. Med. Chem. Lett. 23, 3064-3069 (2013).
85. Doerig, C. et al. Malaria: targeting parasite and host cell kinomes. Biochim. Biophys. Acta 1804, 604-612 (2010).
86. Sicard, A. et al. Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes. Cell. Microbiol. 13, 836-845 (2011).
87. Malmquist, N. A., Moss, T. A., Mecheri, S., Scherf, A.&Fuchter, M. J. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 109, 16708-16713 (2012).
88. Dembele, L. et al. Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures. Nature Med. 20, 307-312 (2014).
89. Darkin-Rattray, S. J. et al. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc. Natl Acad. Sci. USA 93, 13143-13147 (1996).
90. Andrews, K. T. et al. Potent antimalarial activity of histone deacetylase inhibitor analogues. Antimicrob. Agents Chemother. 52, 1454-1461 (2008).
91. Patel, V. et al. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. J. Med. Chem. 52, 2185-2187 (2009).
92. Rackham, M. D. et al. Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase. J. Med. Chem. 56, 371-375 (2013).
93. Goncalves, V. et al. Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode. J. Med. Chem. 55, 3578-3582 (2012).
94. Bell, A. S. et al. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs. PLoS Negl. Trop. Dis. 6, e1625 (2012).
95. Resh, M. D. Targeting protein lipidation in disease. Trends Mol. Med. 18, 206-214 (2012).
96. Nallan, L. et al. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. J. Med. Chem. 48, 3704-3713 (2005).
97. Dekker, F. J. et al. Small-molecule inhibition of APT1 affects Ras localization and signaling. Nature Chem. Biol. 6, 449-456 (2010).
98. Child, M. A. et al. Small-molecule inhibition of a depalmitoylase enhances Toxoplasma host-cell invasion. Nature Chem. Biol. 9, 651-656 (2013).
99. Macek, B. et al. Phosphoproteome analysis of E. coli reveals evolutionary conservation of bacterial Ser/Thr/Tyr phosphorylation. Mol. Cell Proteom. 7, 299-307 (2008).
100. Gruhler, A. et al. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol. Cell Proteom. 4, 310-327 (2005).
101. Olsen, J. V. et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648 (2006).
102. Moser, K.&White, F. M. Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS. J. Proteome Res. 5, 98-104 (2006).
103. Kruger, M. et al. SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 134, 353-364 (2008).
104. Donald, R. G. et al. Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase. Mol. Biochem. Parasitol. 149, 86-98 (2006).
105. Resh, M. D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451, 1-16 (1999).
106. Trelle, M. B., Salcedo-Amaya, A. M., Cohen, A. M., Stunnenberg, H. G.&Jensen, O. N. Global histone analysis by mass spectrometry reveals a high content of acetylated lysine residues in the malaria parasite Plasmodium falciparum. J. Proteome Res. 8, 3439-3450 (2009).
107. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007).
108. Jenuwein, T.&Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001).
109. Miranda-Saavedra, D., Gabaldon, T., Barton, G. J., Langsley, G.&Doerig, C. The kinomes of apicomplexan parasites. Microbes Infect. 14, 796-810 (2012).
110. Schneider, A. G.&Mercereau-Puijalon, O. A new Apicomplexa-specific protein kinase family: multiple members in Plasmodium falciparum, all with an export signature. BMC Genom. 6, 30 (2005).
111. Peixoto, L. et al. Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. Cell Host Microbe 8, 208-218 (2010).
112. Zhang, M., Joyce, B. R., Sullivan, W. J. Jr&Nussenzweig, V. Translational control in Plasmodium and Toxoplasma parasites. Eukaryot. Cell 12, 161-167 (2013).
113. Sullivan, W. J. Jr, Narasimhan, J., Bhatti, M. M.&Wek, R. C. Parasite-specific eIF2 (eukaryotic initiation factor-2) kinase required for stress-induced translation control. Biochem. J. 380, 523-531 (2004).
114. Gissot, M., Kelly, K. A., Ajioka, J. W., Greally, J. M.&Kim, K. Epigenomic modifications predict active promoters and gene structure in Toxoplasma gondii. PLoS Pathog. 3, e77 (2007).
115. Brooks, C. F. et al. Toxoplasma gondii sequesters centromeres to a specific nuclear region throughout the cell cycle. Proc. Natl Acad. Sci. USA 108, 3767-3772 (2011).
116. Heaslip, A. T., Nishi, M., Stein, B.&Hu, K. The motility of a human parasite, Toxoplasma gondii, is regulated by a novel lysine methyltransferase. PLoS Pathog. 7, e1002201 (2011).
117. Kemp, L. E. et al. Characterization of a serine hydrolase targeted by acyl-protein thioesterase inhibitors in Toxoplasma gondii. J. Biol. Chem. 288, 27002-27018 (2013).
118. Wirth, D. F. Biological revelations. Nature 419, 495-496 (2002).
119. Kafsack, B. F. et al. A transcriptional switch underlies commitment to sexual development in malaria parasites. Nature 507, 248-252 (2014).
120. Webster, W. A.&McFadden, G. I. From the genome to the phenome: tools to understand the basic biology of Plasmodium falciparum. J. Eukaryot. Microbiol. 61, 655-671 (2014).